Description
Colizor – 2MIU containing Colistimethate Sodium Injection IP 2 Million IU is a powerful last-line antibiotic widely used in hospitals for treating severe infections caused by multidrug-resistant Gram-negative bacteria. As a polymyxin-class antibiotic, Colizor plays a crucial role in combating pathogens that are resistant to conventional antibiotics, making it a reliable choice in critical care settings.
Key Benefits of Colizor – 2MIU
- Effective against multidrug-resistant bacterial infections
- Trusted polymyxin antibiotic for critical conditions
- Suitable for hospital and ICU use
- High potency 2MIU dosage for severe infections
- Helps manage life-threatening respiratory and bloodstream infections
Colizor is supplied in a vial format, ensuring stability and easy administration. The dosage and duration should always be determined by healthcare professionals to minimize potential side effects such as nephrotoxicity or neurotoxicity.
Conclusion
Colizor – 2MIU stands as a dependable antibiotic solution for healthcare providers dealing with resistant infections. Its potent formulation ensures targeted action, helping improve patient outcomes in serious medical conditions.
